Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-16 4:34 pm Sale | 13G | TYME TECHNOLOGIES, INC. CO TYME | Hoffman Steve | 0 0% | -22,397,566 (Position Closed) | View |
| 2022-09-16 4:31 pm Sale | 13D | SYROS PHARMACEUTICALS INC SYRS | TYME TECHNOLOGIES INC. TYME | 0 0% | -17,460,552 (Position Closed) | View |
| 2022-07-13 5:15 pm Purchase | 13D | SYROS PHARMACEUTICALS INC SYRS | TYME TECHNOLOGIES INC. TYME | 17,460,552 28% | 17,460,552 (New Position) | View |
| 2022-07-13 5:10 pm Purchase | 13D | TYME TECHNOLOGIES, INC. CO TYME | Syros Pharmaceuticals Inc. SYRS | 17,819,723 9.9% | 17,819,723 (New Position) | View |
| 2022-02-08 07:00 am Sale | 13G | TYME TECHNOLOGIES, INC. CO TYME | Hoffman Steve | 22,397,566 13% | -3,140,182 (-12.30%) | View |
| 2021-02-12 4:07 pm Sale | 13G | TYME TECHNOLOGIES, INC. CO TYME | Hoffman Steve | 25,537,748 19.6% | -1,455,000 (-5.39%) | View |
| 2020-02-14 1:09 pm Sale | 13G | TYME TECHNOLOGIES, INC. CO TYME | Demurjian Michael | 24,070,521 19.9% | -2,912,222 (-10.79%) | View |
| 2020-02-13 08:01 am Purchase | 13G | TYME TECHNOLOGIES, INC. CO TYME | Hoffman Steve | 26,992,748 21.9% | 52,778 (+0.20%) | View |
| 2020-01-17 07:00 am Purchase | 13G | TYME TECHNOLOGIES, INC. CO TYME | EAGLE PHARMACEUTICALS INC. EGRX | 10,000,000 8.2% | 10,000,000 (New Position) | View |